Moviprep

Polyethylene glycol electrolyte solution, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is used to cleanse the bowel in adults undergoing colonoscopy or sigmoidoscopy procedures and to facilitate visualization of the intestinal mucosa.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution. Including temperature‑controlled shipping where required.

Moviprep is an osmotic laxative used for bowel preparation in gastrointestinal endoscopic procedures. - Colonoscopy: provides thorough cleansing of the colon to enable clear visualization during the procedure. - Sigmoidoscopy: clears the distal colon and rectum to facilitate examination of the sigmoid colon. - Pre‑procedure imaging: prepares the bowel for radiologic studies such as CT colonography where a clean colon is required.

Moviprep may cause a range of adverse reactions, most of which are related to its osmotic activity and electrolyte composition. Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal cramping: intermittent pain or discomfort in the abdomen. - Diarrhea: loose, watery stools during the cleansing process. - Bloating: sensation of abdominal fullness or gas. Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids leading to dizziness or low blood pressure. - Electrolyte imbalance: abnormal serum levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Renal impairment: worsening kidney function in susceptible individuals.

When using Moviprep, several precautions should be observed to ensure safety and effectiveness. - Assess renal function: evaluate kidney status before administration, especially in patients with known impairment. - Review electrolyte status: check serum sodium and potassium levels to avoid significant shifts. - Fluid intake: encourage adequate oral fluids during preparation to reduce risk of dehydration. - Contraindications: avoid use in patients with known bowel obstruction or perforation. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Moviprep can interact with other medicines, primarily through its effect on fluid and electrolyte balance. Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss and dehydration. - Sodium‑containing laxatives: increase risk of fluid overload and electrolyte disturbances. - Antihypertensive agents: potential for enhanced hypotensive effect due to volume depletion. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and renal function during preparation. - Anticoagulants: assess bleeding risk if severe diarrhea leads to mucosal irritation. - Oral rehydration solutions: coordinate timing to maintain appropriate electrolyte balance.